Journal article
A phase 2, single agent study of CI-1033 administered at two doses in ovarian cancer patients who failed platinum therapy
Authors
Campos SM; Seiden MV; Oza A; Plante M; Potkul R; Hamid O; Lenehan P; Kaldjian E; Jordan C; Hirte H
Journal
Journal of Clinical Oncology, Vol. 22, No. 14_suppl, pp. 5054–5054
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
July 15, 2004
DOI
10.1200/jco.2004.22.14_suppl.5054
ISSN
0732-183X